vor 5 Jahren

Bayer beantragt in China weitere Zulassung für Prostata-Krebsmittel

BERLIN/SAN FRANCISCO (dpa-AFX) - Bayer will seinen Hoffnungsträger Nubeqa gegen Prostatakrebs in China bei einer weiteren Patientengruppe einsetzen. Bei der chinesischen Arzneimittelbehörde NMPA sei ein Antrag zur Zulassung des Wirkstoffs Darolutamid in Kombination mit der Chemotherapie Docetaxel bei Patienten...

Quelle: Börse Online RSS Feed

SeedSigner 180 degrees rotated UI with the joystick to the rightvor 9 Stunden
Trump Media moves $342 million in bitcoin to Crypto.com, blockchain data showvor 10 Stunden
SATOSHI - 18 years ago - "We can win a major battle.. and gain a new territory of freedom for several years."vor 22 Stunden
Jack Mallers explains why he keeps DCAing into Bitcoin, top or bottom:vor 23 Stunden
India’s first Bitcoin-backed INR lending platform is now live (pilot)vor 23 Stunden
Mr. Bitcoin someone told me you was deadvor 24 Stunden
Bought the rumor so I could sell the newsvor 24 Stunden
Can I say the "we are so back" line now?vor 1 Tag
imagine being bullish on something majorly valued in a ish coin like the u.s. dollar that has lost over 98% of its value in the last 100 year.vor 1 Tag
I’ve reached my second goal! 0.02 in BTCvor 1 Tag